title: Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.
authors.forename: Sonja A
authors.initials: SA
authors.lastname: Grundmann
authors.forename: Pia B
authors.initials: PB
authors.lastname: Hemfort
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Luger
authors.forename: Randolf
authors.initials: R
authors.lastname: Brehler
mesh_terms: D000368:Aged; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000628:therapy; D002908:Chronic Disease / Q000628:therapy; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D008297:Male; D000069444:Omalizumab; D011859:Radiography; D012220:Rhinitis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy; D012852:Sinusitis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E